D. Shay

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
D. K. Shay, David K. Shay, David K Shay, D K Shay, David Shay
Publication record
179 papers · 23,315 citations · H-index 72

PAPERS

Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021.
2022577 citationsauthor #2
Myocarditis Cases After mRNA-Based COVID-19 Vaccination in the US-Reply.
202218 citationsauthor #2
Reactogenicity of Simultaneous COVID-19 mRNA Booster and Influenza Vaccination in the US
202242 citationsauthor #10
Myocarditis Occurring After Immunization With mRNA-Based COVID-19 Vaccines.
202199 citationsauthor #1
COVID-19 Vaccine Safety in Adolescents Aged 12–17 Years — United States, December 14, 2020–July 16, 2021
2021137 citationsauthor #12
Anxiety-Related Adverse Event Clusters After Janssen COVID-19 Vaccination — Five U.S. Mass Vaccination Sites, April 2021
202167 citationsauthor #9
Reactogenicity within 2 weeks after mRNA COVID-19 vaccines: Findings from the CDC v-safe surveillance system
202120 citationsauthor #4
Use of High-Dose Influenza and Live Attenuated Influenza Vaccines by US Primary Care Physicians
20211 citationsauthor #9
Impact of diabetes status on immunogenicity of trivalent inactivated influenza vaccine in older adults
20216 citationsauthor #12
Safety Monitoring of an Additional Dose of COVID-19 Vaccine — United States, August 12–September 19, 2021
202175 citationsauthor #7
COVID-19 Vaccination and Non–COVID-19 Mortality Risk — Seven Integrated Health Care Organizations, United States, December 14, 2020–July 31, 2021
2021108 citationsauthor #7
COVID-19 Vaccine Safety in Children Aged 5–11 Years — United States, November 3–December 19, 2021
2021145 citationsauthor #10
Influenza vaccination rates and hospitalizations among Medicaid enrollees with and without sickle cell disease, 2009–2015
20218 citationsauthor #5
Safety Monitoring of the Janssen (Johnson & Johnson) COVID-19 Vaccine — United States, March–April 2021
2021169 citationsauthor #1
Patterns of seasonal influenza activity in U.S. core-based statistical areas, described using prescriptions of oseltamivir in Medicare claims data
201811 citationsauthor #2
Evaluating oseltamivir prescriptions in Centers for Medicare and Medicaid Services medical claims records as an indicator of seasonal influenza in the United States
201810 citationsauthor #2
Estimated rates of influenza‐associated outpatient visits during 2001‐2010 in 6 US integrated healthcare delivery organizations
20188 citationsauthor #12
Statin Use and Risks of Influenza-Related Outcomes Among Older Adults Receiving Standard-Dose or High-Dose Influenza Vaccines Through Medicare During 2010–2015
201817 citationsauthor #14
Effectiveness of Influenza Vaccine in Preventing Death among Ontario Residents Aged ≥65 Years during 20 Seasons
20171 citationsauthor #1
Comparative Effectiveness of High-Dose Versus Standard-Dose Influenza Vaccines Among US Medicare Beneficiaries in Preventing Postinfluenza Deaths During 2012–2013 and 2013–2014
2017110 citationsauthor #1
Estimating Influenza Vaccination Status Among Medicare Beneficiaries: Comparison of Billing Claims and Vaccination Data Obtained from Medical Records and Self-report
20170 citationsauthor #8
School‐Based Influenza Vaccination: Health and Economic Impact of Maine's 2009 Influenza Vaccination Program
20179 citationsauthor #14
High-dose influenza vaccine favors acute plasmablast responses rather than long-term cellular responses.
201623 citationsauthor #10
Incidence and viral aetiologies of acute respiratory illnesses (ARIs) in the United States: a population-based study
201617 citationsauthor #10
Case-Control Study of Vaccine Effectiveness in Preventing Laboratory-Confirmed Influenza Hospitalizations in Older Adults, United States, 2010-2011.
201632 citationsauthor #3
Seasonal Influenza Vaccination of Children Induces Humoral and Cell-Mediated Immunity Beyond the Current Season: Cross-reactivity With Past and Future Strains.
201617 citationsauthor #10
Age, serum 25-hydroxyvitamin D and vitamin D receptor (VDR) expression and function in peripheral blood mononuclear cells
201613 citationsauthor #13
Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis.
2015168 citationsauthor #3
Influenza-Related Hospitalization and ED Visits in Children Less Than 5 Years: 2000–2011
201545 citationsauthor #10
Deaths averted by influenza vaccination in the U.S. during the seasons 2005/06 through 2013/14☆
201579 citationsauthor #4
Corrections. Comparative effectiveness of high-dose versus standard-dose influenza vaccines in US residents aged 65 years and older from 2012 to 2013 using Medicare data: a retrospective cohort analysis.
20152 citationsauthor #3
Preexisting Immunity, More Than Aging, Influences Influenza Vaccine Responses
201536 citationsauthor #25
Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates.
2014342 citationsauthor #19
A probability model for evaluating the bias and precision of influenza vaccine effectiveness estimates from case-control studies
201441 citationsauthor #4
Vitamin E, vitamin A, and zinc status are not related to serologic response to influenza vaccine in older adults: an observational prospective cohort study.
201414 citationsauthor #4
Reply to Fedson.
20140 citationsauthor #5
The Burden of Influenza-Associated Critical Illness Hospitalizations*
201473 citationsauthor #3
Can the rolling cross-sectional survey design be used to estimate the effectiveness of influenza vaccines?
20144 citationsauthor #7
Demographic, socio-economic and geographic determinants of seasonal influenza vaccine uptake in rural western Kenya, 2011.
201427 citationsauthor #10
Age-Specific Influenza-Related Emergency Department Visits and Hospitalizations in 2010–2011 Compared With the Pandemic Year 2009–2010
20143 citationsauthor #7
Unraveling R0: considerations for public health applications.
201461 citationsauthor #3
Unraveling R0: Considerations for Public Health Applications
2014167 citationsauthor #3
Influence of pre-existing hemagglutination inhibition titers against historical influenza strains on antibody response to inactivated trivalent influenza vaccine in adults 50–80 years of age
201418 citationsauthor #6
Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010-2011 and 2011-2012 influenza seasons.
2014153 citationsauthor #16
Subjective social status predicts wintertime febrile acute respiratory illness among women healthcare personnel.
201413 citationsauthor #9
Influenza Pneumonia Surveillance among Hospitalized Adults May Underestimate the Burden of Severe Influenza Disease
201425 citationsauthor #6
Effectiveness of Nonadjuvanted Monovalent Influenza A(H1N1)pdm09 Vaccines for Preventing Reverse Transcription Polymerase Chain Reaction–Confirmed Pandemic Influenza Hospitalizations: Case-Control Study of Children and Adults at 10 US Influenza Surveillance Network Sites
201313 citationsauthor #19
Effectiveness of Inactivated Influenza Vaccines in Preventing Influenza-Associated Deaths and Hospitalizations among Ontario Residents Aged ≥65 Years: Estimates with Generalized Linear Models Accounting for Healthy Vaccinee Effects
201342 citationsauthor #8
Influenza vaccine effectiveness in the community and the household.
2013192 citationsauthor #6
Regional variation in mortality impact of the 2009 A(H1N1) influenza pandemic in China
201342 citationsauthor #4
Effect of the 2009 influenza A(H1N1) pandemic on invasive pneumococcal pneumonia.
201338 citationsauthor #8
Trends in mortality from respiratory disease in Latin America since 1998 and the impact of the 2009 influenza pandemic.
201316 citationsauthor #13
Population-based incidence estimates of influenza-associated respiratory failure hospitalizations, 2003 to 2009.
201346 citationsauthor #5
Influenza Illness and Hospitalizations Averted by Influenza Vaccination in the United States, 2005–2011
2013210 citationsauthor #6
The case test-negative design for studies of the effectiveness of influenza vaccine.
2013272 citationsauthor #4
Risk of adverse events following oseltamivir treatment in influenza outpatients, Vaccine Safety Datalink Project, 2007–2010
201320 citationsauthor #3
Further Evidence for Bias in Observational Studies of Influenza Vaccine Effectiveness: The 2009 Influenza A(H1N1) Pandemic
201347 citationsauthor #9
Prevention and control of seasonal influenza with vaccines. Recommendations of the Advisory Committee on Immunization Practices--United States, 2013-2014.
2013350 citationsauthor #2
Innate Immune Function and Mortality in Critically Ill Children With Influenza: A Multicenter Study*
2013146 citationsauthor #7
Effectiveness of monovalent 2009 pandemic influenza A virus subtype H1N1 and 2010-2011 trivalent inactivated influenza vaccines in Wisconsin during the 2010-2011 influenza season.
201325 citationsauthor #5
Early Estimates of Seasonal Influenza Vaccine Effectiveness — United States, January 2013
2013167 citationsauthor #53
Inactivated Influenza Vaccines for Prevention of Community-Acquired Pneumonia: The Limits of Using Nonspecific Outcomes in Vaccine Effectiveness Studies
201323 citationsauthor #6
Hospitalizations associated with influenza and respiratory syncytial virus in the United States, 1993-2008.
2012558 citationsauthor #10
Evaluation of obesity as an independent risk factor for medically attended laboratory‐confirmed influenza
201227 citationsauthor #5
Association between obesity and vulnerability and serologic response to influenza vaccination in older adults.
201290 citationsauthor #7
A large, population-based study of 2009 pandemic Influenza A virus subtype H1N1 infection diagnosis during pregnancy and outcomes for mothers and neonates.
201250 citationsauthor #9
Incidence of influenza‐associated mortality and hospitalizations in Argentina during 2002–2009
201226 citationsauthor #17
Immunosenescence and Challenges of Vaccination against Influenza in the Aging Population.
2012136 citationsauthor #6
Time-series analyses of count data to estimate the burden of seasonal infectious diseases.
201223 citationsauthor #4
Diagnostic performance of the BinaxNow Influenza A&B rapid antigen test in ED patients.
201218 citationsauthor #8
Immunoglobulins and Risk of Autism Prenatal and Infant Exposure to Thimerosal From Vaccines and
20120 citationsauthor #3
The expected emotional benefits of influenza vaccination strongly affect pre-season intentions and subsequent vaccination among healthcare personnel.
201249 citationsauthor #14
Emergency Department Visits for Influenza A(H1N1)pdm09, Davidson County, Tennessee, USA
201212 citationsauthor #9
Magnitude of potential biases in a simulated case-control study of the effectiveness of influenza vaccination.
201236 citationsauthor #2
Influenza-associated mortality in temperate and subtropical Chinese cities, 2003-2008.
2012146 citationsauthor #2
Vitamin D, influenza vaccine response, and respiratory illness
20121 citationsauthor #8
Estimated global mortality associated with the first 12 months of 2009 pandemic influenza A H1N1 virus circulation: a modelling study.
20121,254 citationsauthor #5
Estimating age‐specific influenza‐related hospitalization rates during the pandemic (H1N1) 2009 in Davidson Co, TN
201225 citationsauthor #9
Household economic impact and attitudes toward school closures in two cities in Argentina during the 2009 influenza A (H1N1) pandemic
201217 citationsauthor #8
Effects of immunizing school children with 2009 influenza A (H1N1) monovalent vaccine on absenteeism among students and teachers in Maine.
201223 citationsauthor #15
Comparison of Nasal and Nasopharyngeal Swabs for Influenza Detection in Adults
201258 citationsauthor #3
Patterns in influenza antiviral medication use before and during the 2009 H1N1 pandemic, Vaccine Safety Datalink Project, 2000–2010
201217 citationsauthor #2
Influenza-associated excess mortality in southern Brazil, 1980–2008
201226 citationsauthor #7
Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains.
2012258 citationsauthor #16
Effectiveness of 1 dose of influenza A (H1N1) 2009 monovalent vaccines in preventing reverse-transcription polymerase chain reaction-confirmed H1N1 infection among school-aged children in maine.
201224 citationsauthor #13
Comparison of clinical features and outcomes of medically attended influenza A and influenza B in a defined population over four seasons: 2004–2005 through 2007–2008
201199 citationsauthor #6
BMI is not a risk factor for medically attended influenza
20110 citationsauthor #5
The Pregnancy and Influenza Project: design of an observational case-cohort study to evaluate influenza burden and vaccine effectiveness among pregnant women and their infants.
201120 citationsauthor #9
Effectiveness of Non-Adjuvanted Pandemic Influenza A Vaccines for Preventing Pandemic Influenza Acute Respiratory Illness Visits in 4 U.S. Communities
2011126 citationsauthor #17
A Pilot Study of Host Genetic Variants Associated with Influenza-associated Deaths among Children and Young Adults
201125 citationsauthor #8
Comparing Severity and Outcomes for Seasonal and 2009 H1N1 Infections—Reply
20110 citationsauthor #2
Improving immunogenicity and effectiveness of influenza vaccine in older adults
201132 citationsauthor #6
Influenza vaccination status is not associated with influenza testing among children: implications for observational studies of vaccine effectiveness.
201117 citationsauthor #4
Influenza vaccine effectiveness in Wisconsin during the 2007-08 season: comparison of interim and final results.
201195 citationsauthor #10
Vitamin D Binding Protein Gene Polymorphisms Are Associated With Clinical Outcomes In Children And Young Adults With Life-Threatening Influenza
20110 citationsauthor #5
Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP).
2011781 citationsauthor #3
Monitoring Influenza Activity in the United States: A Comparison of Traditional Surveillance Systems with Google Flu Trends
2011158 citationsauthor #3
Comparison of influenza vaccine effectiveness using different methods of case detection: clinician-ordered rapid antigen tests vs. active surveillance and testing with real-time reverse-transcriptase polymerase chain reaction (rRT-PCR).
201124 citationsauthor #4
Risk Factors For Mortality In Children Admitted To The ICU With Influenza Infection
20101 citationsauthor #16
Studies Needed to Address Public Health Challenges of the 2009 H1N1 Influenza Pandemic: Insights from Modeling
201090 citationsauthor #13

TIMELINE

1994 200 citations

1995 361 citations

1997 166 citations

1998 0 citations

1999 1,624 citations

2000 1,589 citations

2001 491 citations

2002 84 citations

2003 904 citations

2004 2,900 citations

2005 1,284 citations

2006 1,542 citations

2007 876 citations

2008 326 citations

2009 1,147 citations

2010 910 citations

2011 1,377 citations

2012 2,874 citations

2013 1,649 citations

2014 941 citations

2015 330 citations

2016 102 citations

2017 120 citations

2018 46 citations

2021 835 citations

2022 637 citations

D. Shay

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT